by Jordana Choucair | Nov 3, 2021 | Health IT
FAIR Health’s Monthly Telehealth Regional Tracker shows that telehealth use among individuals with private health insurance increased by almost 13 percent from July to August. The top five reasons for telehealth visits in August were mental health conditions...
by Jordana Choucair | Nov 3, 2021 | Life Sciences
CDC Director Dr. Rochelle Walensky endorsed a recommendation for vaccinating children ages 5-11 against COVID-19. The endorsement came after a group of CDC advisers voted 14-0 t to recommend Pfizer’s COVID-19 vaccine for children. During the approval process,...
by Jordana Choucair | Nov 3, 2021 | D.C. News
Senate Democrats have reached an agreement to lower prescription drug prices. The deal hits on Democrats’ three main pillars of drug price reform: It would allow Medicare to negotiate the prices of some drugs; it would put a cap on how much drugmakers can hike...
by Jordana Choucair | Nov 2, 2021 | Opioid/Substance Use Disorders
A superior court judge in California became the first judge to reject government claims that opioid makers should be held responsible for the addiction crisis. The judge ruled that a handful of opioid manufacturers, including Johnson & Johnson, Teva Pharmaceutical...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Eli Lilly and Co. announced that the U.S. government bought 614,000 additional doses of its COVID-19 antibody therapy for $1.29 billion. As part of the agreement, Lilly will supply a minimum of 400,000 doses of bamlanivimab with etesevimab no later than December 31,...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Pfizer said its COVID-19 vaccine brought in $13 billion in sales in the third quarter and boosted its year-end forecast to $36 billion due to global deals for booster shots and broader eligibility for the vaccine. The company said it plans to deliver 2.3 billion doses...
Recent Comments